UnknownNot Applicable

Transverse Maxillary Expansion With a Segmental Le Fort I Osteotomy or Surgically Assisted Rapid Maxillary Expansion (SARME)

Denmark90 participantsStarted 2016-08-01

Plain-language summary

To assess transverse dental and skeletal expansion and stability after SLFIO with no fixation of the palatal vault compared to stabilization of the palatal vault with an autogenous bone block graft or fixation of the palatal osteotomy site with a biodegradable plate. To assess transverse maxillary dental and skeletal expansion and stability after SARME with a TB distraction appliance compared to a BB distraction appliance.

Who can participate

Age range15 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Mature non-syndromic patients scheduled for transverse expansion of the maxilla Exclusion Criteria: Previous orthognathic surgery involving the maxilla Congenital maxillofacial deformities

What they're measuring

Skeletal relapse

Timeframe: 2 years

Trial details

NCT IDNCT03511989

SponsorAalborg University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-01

Contact for this trial

Tue L Blæhr, DDS

t.blaehr@rn.dk

View on ClinicalTrials.gov More Maxilla; Hypoplasia trials